Gene Query: OGT

Dataset Description Geneva Score
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 50.87
LNCaP treated with iBET 48.75
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 45.54
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 43.32
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 39.21
Global response to chemotherapy-induced apoptosis 38.85
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 38.66
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 35.41
RNA-Seq analysis of breast cancer cells after shikonin treatment 34.24
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 32.05
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 32.0
Electronic cigarettes 31.99
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 31.75
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 31.75
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 31.55
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 31.33
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 31.33
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 30.07
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 29.76
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 28.92
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 28.45
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 27.85
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 27.5
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 27.29
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 26.81
Altering cancer transcriptomes using epigenomic inhibitors 26.81
High-throughput sequencing of PROMPT-enriched samples. 26.58
Functional role of SLIT2 and ROBO1 in trophoblasts 26.27
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 26.17
Argonaute proteins couple chromatin silencing to alternative splicing 26.17
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 25.93
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 25.24
Gene expression profile of human iPSC-derived nephron progenitor cells 25.04
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 24.33
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 24.29
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 24.08
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 23.6
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 23.51
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 23.2
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 23.07
Rorc disruption in human FG pancreatic cancer cells 22.65
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 22.48
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 22.39
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 22.28
LncRNA-GAS5 negative regulation of YAP-target genes expression 22.25
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 21.86
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 21.13
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 21.1
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 21.07
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 20.86
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 20.07
Systematic discovery of endogenous human ribonucleoprotein complexes 20.03
Expression level comparison under dividing and quiescent states in human primary fibroblasts 20.0
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 19.87
Profiling of escape kinetics of viruses subjected to RNAi 19.77
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 19.46
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 19.03
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 18.97
3’ Uridylation Expands miRNA Target Repertoire 18.9
Transcriptomic analyssis following EHMT1/2 inhibition 18.66
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 18.52
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 18.42
Differetially expressed genes after hTR overexpression in U2OS cells 18.22
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 17.99
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 17.92
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 17.83
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 17.79
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 17.74
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 17.69
An optimization system for isolating and sequencing of single human colon cancer cells 17.61
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 17.49
Role of XRN2 ribonucleolytic activity in RNA metabolism 17.4
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 17.38
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 17.36
Role of microRNAs in the interaction between Salmonella and the host cell 17.33
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 17.18
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 16.91
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 16.82
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 16.81
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 16.1
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 15.98
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 15.98
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 15.9
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 15.88
circRNA-sequencing 15.88
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 15.76
Regulation of highly expressed hCINAP on translatome 15.75
Genes significantly down or Up-regulated upon RNF219 knockdown 15.72
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 15.64
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 15.45
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 15.43
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 15.13
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 15.09
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 14.95
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 14.89
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 14.79
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 14.78
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 14.61
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 14.59
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 14.47
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 14.14
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 14.09
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 14.02
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 14.0
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 13.98
Gene expressions of H9s in different culture systems 13.93
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 13.88
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 13.87
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 13.82
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 13.82
Cleavage Factor Im as a key regulator of 3’ UTR length 13.8
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 13.74
Defective structural RNA processing in relapsing-remitting multiple sclerosis 13.72
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 13.63
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 13.58
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 13.45
Transcriptomic analysis of the HOTAIR-regulated genes 13.39
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 13.36
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 13.34
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 13.33
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 13.32
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 13.17
RNA-seq of naive and primed ES cells 13.06
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 13.06
Solid phase chemistry to covalently and reversibly capture thiolated RNA 13.04
Generation of KRAS signatures using immortalized isogenic lung cells. 13.01
Co-transcriptional loading of RNA export factors shapes the human transcriptome 13.0
RNAseq of HEK293 cells after Chtop knockdown 13.0
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 12.98
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 12.93
Neurofibroma 12.93
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 12.8
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 12.73
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 12.73
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 12.73
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 12.68
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 12.65
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 12.65
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 12.58
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 12.53
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 12.53
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 12.5
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 12.4
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 12.4
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 12.39
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 12.38
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 12.37
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 12.34
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 12.27
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 12.23
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 12.11
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 12.1
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 11.98
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 11.91
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 11.84
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 11.82
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 11.7
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 11.68
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 11.65
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 11.64
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 11.64
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 11.63
Integrating single-cell transcriptomic data across different conditions, technologies, and species 11.59
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 11.46
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 11.46
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 11.26
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 11.21
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 11.21
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 11.19
Short and Long RNA sequencing of human mature erythrocytes 11.15
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 11.11
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 11.04
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 11.04
Overexpression of NFIB and YBX1 in MCF-7 cells 10.94
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 10.94
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 10.84
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 10.84
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 10.8
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 10.77
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 10.65
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.6
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 10.55
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 10.54
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 10.52
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 10.49
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 10.46
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 10.4
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 10.38
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 10.35
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 10.35
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 10.3
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 10.24
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 10.15
MYC dependent mRNA translation shapes gene expression and cell biology 10.03
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 10.01
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 10.0
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 10.0
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 9.99
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 9.95
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 9.92
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 9.87
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 9.83
Gene Expression Profiling of SPOP Knocked Down Cell 9.82
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 9.76
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 9.72
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 9.71
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 9.69
Expression data from miR340 overexpressing human A549 cells 9.67
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 9.66
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 9.66
Single-Cell Genotyping of Transcriptomes 9.62
RNA-seq of Single-Cell Genotyping of Transcriptomes 9.62
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 9.56
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 9.54
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 9.49
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 9.49
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.47
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 9.36
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 9.36
Molecular Criteria for Defining the Naive Human Pluripotent State 9.31
m6A-dependent regulation of messenger RNA stability 9.27
X-Ray induced DNA-Hydroxymethylation changes 9.22
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 9.21
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 9.15
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 9.14
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 9.11
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 9.09
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 9.08
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 9.08
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 9.08
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 9.08
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 9.0
Exploring the RNA landscape of endothelial exosomes 8.96
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 8.94
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 8.91
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 8.71
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.64
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 8.63
mRNA expression in human DAOY cells 8.58
A transcriptome dataset revealing the molecular features of breast cancer stem cells 8.58
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 8.57
Regulatory network controlling tumor-promoting inflammation in human cancers 8.51
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 8.51
Human cells contain natural double-stranded RNAs with potential regulatory capacity 8.47
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 8.44
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 8.38
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 8.35
Anti-inflammatory effect of indoleacrylic acid (IA) 8.31
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 8.3
RNA editing in nascent RNA affects pre-mRNA splicing 8.29
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 8.14
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 8.12
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 8.04
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 8.0
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 7.95
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 7.94
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 7.94
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 7.89
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 7.86
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 7.81
Regulation of Lipids is Central to Replicative Senescence 7.76
Active translatome profiling with RiboLace in MCF7 cells 7.71
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 7.62
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.6
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 7.51
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 7.51
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 7.5
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 7.43
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 7.39
Effect of BMP inhibition or stimulation of primary human keratinocytes 7.3
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 7.3
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 7.25
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 7.25
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 7.25
Transcriptome analysis of kidney organoids 7.17
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 7.16
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 7.15
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 7.13
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 7.1
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 7.08
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 7.02
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 7.02
Identification of renal resident macrophages across species [C1] 7.01
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 6.96
RNA-seq of RKO cells with cTAZ KO or putback 6.93
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 6.83
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 6.82
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 6.79
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 6.78
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 6.76
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 6.74
MRTF activates TEAD-YAP target gene expression 6.73
Determination of tRNA aminoacylation levels by high throughput sequencing 6.7
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 6.65
In situ CAPTURE of chromatin interactions by biotinylated dCas9 6.6
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 6.6
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 6.58
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 6.57
quanTIseq: quantifying immune contexture of human tumors 6.54
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 6.49
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.49
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 6.46
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 6.43
NR2F2 study 6.43
Aneuploidy-induced cellular stresses limit autophagic degradation. 6.43
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 6.4
miR-93 Targets in Human Endothelial Cells 6.28
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 6.19
RNA-Seq analysis of human colorectal cancer with liver metastasis 6.17
METTL3 and WTAP 6.1
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 6.05
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 5.81
RNA transcriptome analysis during HSV-1 infection 5.74
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 5.61
A20 regulates canonical wnt-signaling through an interaction with RIPK4 5.6
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 5.58
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.57
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.57
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 5.4
Copper Regulation of HIF-1 Transcription Activity 5.38
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 5.38
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 5.36
STRIPAK directs PP2A activity to promote oncogenic transformation 5.3
Human Treg NaCl stimulation 5.16
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 4.98
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 4.92
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 4.88
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 4.87
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.86
Transcriptomes of oxLDL exposed trained monocytes 4.84
oxLDL exposed trained monocytes 4.84
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 4.73
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 4.54
The bromodomain protein BRD4 regulates splicing during heat shock 4.54
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.53
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.53
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 4.49
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 4.48
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.43
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 4.43
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 4.43
The transcriptome effect of overexpressing EZH2 in MCF7 4.42
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.39
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 4.32
Effect of CHKA knockdown on C4-2 cell transcriptome 4.25
Comparative Analysis of Cas9 Activators Across Multiple Species 4.13
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 4.06
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 4.05
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.98
RNA polymerase in pre-B-ALL cell lines 3.92
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.87
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 3.83
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 3.81
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.79
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 3.71
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.67
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 3.67
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 3.67
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 3.63
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 3.57
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.55
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 3.54
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.43
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.38
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.38
Identification of renal resident macrophages across species 3.31
Transcriptomic profiling of human peripheral blood-derived mast cells 3.29
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 3.29
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 3.26
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.25
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.22
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 3.21
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.14
The circadian transcriptional landscape in primary human mammary epithelial cells 3.11
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 3.1
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.07
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 3.03
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.03
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.99
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.96
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.95
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 2.91
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.89
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.89
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.84
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.84
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 2.81
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 2.81
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.76
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 2.72
Transcriptome analysis of peripheral blood monocytes 2.72
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.65
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.65
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.57
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 2.51
Regulating Interleukin-2 activity with engineered receptor signaling clamps 2.49
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 2.47
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 2.47
Human Tfh cell RNA bulk sequencing 2.42
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.42
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.4
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.36
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.31
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.31
Expression analysis of the TAF1 syndrome 2.31
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.29
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.29
In vitro modeling of human germ cell development using pluripotent stem cells 2.28
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 2.28
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 2.26
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.23
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.15
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 2.11
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  2.11
Effect of PBK knockdown on C4-2 cell transcriptome 2.05
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 2.0
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.0
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 1.97
Exogenous rescue of KLHL9 in SF210 cell line 1.97
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.97
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.86
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 1.83
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.8
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.75
Subtle asymmetry of gene expression in embryonic and foetal human brains 1.72
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.67
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.67
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.65
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.65
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.62
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.61
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 1.61
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.59
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.57
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 1.56
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 1.48
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.45
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.45
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 1.43
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.43
High-resolution comparative analysis of great ape genomes 1.41
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.39
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.38
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.37
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.29
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.26
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 1.24
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 1.24
Gene expression analysis of human adenomas. 1.13
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 1.11
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.05
Transcription elongation regulates genome 3D structure 1.04
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.01
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.01
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.0
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.99
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.95
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.95
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.95
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.87
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.8
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.8
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.75
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.72
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.66
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 0.65
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.62
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 0.58
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.57
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.56
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.55
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.55
Hepatic transcriptome of pediatric hepatoblastoma. 0.55
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.53
A code of mono-phosphorylation modulates the function of RB. 0.52
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.51
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.47
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.46
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 0.4
Human Treg IL-12 stimulation 0.38
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 0.38
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.31
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.27
Effects of transcription on genome - nuclear lamina interactions 0.23
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.23
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.22
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.2
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.17
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.17
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.17
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.11
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.09
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.09
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.09
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 0.07
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.07
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.06
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.05
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation